The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Suri Anish since 2018.
This trader's CIK number is 1739130.
At the time of last reporting, Suri Anish was the PRESIDENT AND CSO of Cue Biopharma, Inc.. (stock ticker symbol CUE).
Also see all insider trading activities at Cue Biopharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | CUE | 4,000 | $11,040 | 0 | $0 | 0 | $0 |
| 2022 | CUE | 0 | $0 | 0 | $0 | 16,668 | $0 |
| 2021 | CUE | 0 | $0 | 48,000 | $750,400 | 81,334 | $322,880 |
| 2020 | CUE | 0 | $0 | 7,000 | $140,122 | 56,999 | $50,276 |
| 2019 | CUE | 0 | $0 | 0 | $0 | 33,333 | $0 |
| 2018 | CUE | 2,000 | $8,740 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-25 | CUE | Buy | 4,000 | 2.76 | 11,040 |
| 2022-03-31 | CUE | Option Ex | 16,668 | .00 | 0 |
| 2021-11-15 | CUE | Option Ex | 8,000 | 8.26 | 66,080 |
| 2021-11-15 | CUE | Sale | 8,000 | 18.05 | 144,400 |
| 2021-11-11 | CUE | Option Ex | 20,000 | 6.42 | 128,400 |
| 2021-11-11 | CUE | Sale | 20,000 | 15.07 | 301,360 |
| 2021-10-03 | CUE | Option Ex | 33,334 | .00 | 0 |
| 2021-09-23 | CUE | Option Ex | 20,000 | 6.42 | 128,400 |
| 2021-09-23 | CUE | Sale | 20,000 | 15.23 | 304,640 |
| 2020-10-03 | CUE | Option Ex | 33,333 | .00 | 0 |
| 2020-08-05 | CUE | Option Ex | 800 | 6.42 | 5,136 |
| 2020-08-05 | CUE | Sale | 800 | 20.01 | 16,008 |
| 2020-08-03 | CUE | Sale | 5,800 | 20.01 | 116,058 |
| 2020-08-04 | CUE | Sale | 400 | 20.14 | 8,056 |
| 2020-08-03 | CUE | Option Ex | 5,800 | 7.34 | 42,572 |
| 2020-08-04 | CUE | Option Ex | 400 | 6.42 | 2,568 |
| 2020-03-31 | CUE | Option Ex | 16,666 | .00 | 0 |
| 2019-11-01 | CUE | Option Ex | 33,333 | .00 | 0 |
| 2018-12-21 | CUE | Buy | 2,000 | 4.37 | 8,740 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Suri Anish (PRESIDENT AND CSO of Cue Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.